State Street Corp Igm Biosciences, Inc. Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, State Street Corp holds 493,698 shares of IGMS stock, worth $617,122. This represents 0.0% of its overall portfolio holdings.

Number of Shares

493,698

Previous 459,451 7.45%

Holding current value

$617,122

Previous $2.81 Million 79.8%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$1.15 - $6.8 $39,384 - $232,879	34,247 Added 7.45%	493,698 $567,000
Q4 2024 Feb 14, 2025	SELL	$6.05 - $17.83 $62,550 - $184,344	-10,339 Reduced 2.2%	459,451 $2.81 Million
Q3 2024 Nov 14, 2024	BUY	$6.28 - $17.68 $76,452 - $215,236	12,174 Added 2.66%	469,790 $7.77 Million
Q2 2024 Aug 14, 2024	BUY	$6.51 - $11.47 $900,638 - $1.59 Million	138,347 Added 43.33%	457,616 $3.14 Million
Q1 2024 May 15, 2024	BUY	$8.68 - $17.36 $102,432 - $204,865	11,801 Added 3.84%	319,269 $3.08 Million
Q4 2023 Feb 14, 2024	BUY	$3.94 - $8.79 $72,381 - $161,481	18,371 Added 6.35%	307,468 $2.56 Million
Q3 2023 Nov 14, 2023	BUY	$6.66 - $10.64 $185,467 - $296,302	27,848 Added 10.66%	289,097 $2.41 Million
Q2 2023 Aug 14, 2023	BUY	$8.86 - $14.0 $278,584 - $440,202	31,443 Added 13.68%	261,249 $2.41 Million
Q1 2023 May 15, 2023	BUY	$13.74 - $25.76 $50,164 - $94,049	3,651 Added 1.61%	229,806 $3.16 Million
Q4 2022 Feb 14, 2023	BUY	$15.45 - $26.02 $64,967 - $109,414	4,205 Added 1.89%	226,155 $3.85 Million
Q3 2022 Nov 15, 2022	BUY	$15.42 - $27.01 $534,904 - $936,949	34,689 Added 18.52%	221,950 $5.05 Million
Q2 2022 Aug 15, 2022	BUY	$13.27 - $25.5 $208,060 - $399,814	15,679 Added 9.14%	187,261 $3.38 Million
Q1 2022 May 16, 2022	SELL	$13.42 - $29.73 $7.52 Million - $16.7 Million	-560,138 Reduced 76.55%	171,582 $4.59 Million
Q4 2021 Feb 14, 2022	BUY	$27.59 - $66.39 $2.09 Million - $5.03 Million	75,697 Added 11.54%	731,720 $21.5 Million
Q3 2021 Nov 15, 2021	BUY	$65.76 - $90.65 $4.55 Million - $6.27 Million	69,185 Added 11.79%	656,023 $43.1 Million
Q2 2021 Aug 16, 2021	SELL	$57.98 - $96.6 $5.82 Million - $9.7 Million	-100,377 Reduced 14.61%	586,838 $48.8 Million
Q1 2021 May 17, 2021	BUY	$71.56 - $121.23 $10.2 Million - $17.3 Million	142,642 Added 26.19%	687,215 $52.7 Million
Q4 2020 Feb 16, 2021	BUY	$47.41 - $115.03 $10.2 Million - $24.8 Million	215,407 Added 65.44%	544,573 $48.1 Million
Q3 2020 Nov 10, 2020	BUY	$43.0 - $84.01 $991,150 - $1.94 Million	23,050 Added 7.53%	329,166 $24.3 Million
Q2 2020 Aug 14, 2020	BUY	$51.3 - $75.21 $11.3 Million - $16.5 Million	219,303 Added 252.62%	306,116 $22.3 Million
Q1 2020 May 11, 2020	BUY	$31.51 - $73.75 $2.74 Million - $6.4 Million	86,813 New	86,813 $4.88 Million

Others Institutions Holding IGMS

# of Institutions

Shares Held

16.2M

Call Options Held

26.8K

Put Options Held

800

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $36.2M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Igm Biosciences, Inc. Transaction History